74. EFFICACY OF HER2-TARGETED THERAPY IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A NATIONAL ANALYSIS

BACKGROUND: Breast cancer brain metastases (BCBM) commonly develop in human epidermal growth factor 2-positive (HER2+) breast cancer, but BCBM patients are underrepresented in clinical trials, leading to a lack of knowledge on the efficacy of HER2-targeted therapy in this population. METHODS: We ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Hulsbergen, Alexander, Broekman, Marike, Smith, Timothy, Iorgulescu, Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401390/
http://dx.doi.org/10.1093/noajnl/vdaa073.061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7401390/
http://dx.doi.org/10.1093/noajnl/vdaa073.061

Ejemplares similares